Delivering Innovative and Complex Oncology Trials
From selecting the right sites and optimizing recruitment to agency submission and review, oncology studies are sensitive in nature and often require specific clinical expertise to properly manage.
At Clinicorp Insights, we understand oncology study nuances: From the ever-changing regulatory landscape to novel and increasingly complex study designs to personalized treatment options, we have you covered. Our comprehensive services and experience give us the flexibility to guide you through dose escalation/expansion studies all the way through global pivotal trials. We share your passion for advancing cancer research and facing the challenges that bring us closer to cures.
Learn more about our oncology study capabilities and experience below:
Solid Tumors
- Advanced solid tumors
- Basal cell carcinoma
- Bladder cancer
- Breast cancer
- Cervical cancer
- Colorectal cancer
- Endometrial carcinoma
- Gastrointestinal cancer
- Glioblastoma multiforme
- Head and neck cancer
- Hepatocellular carcinoma
- Liver metastases
- Melanoma
- Neuroendocrine tumors
- Non-small cell lung cancer
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Renal cell carcinoma
- Small cell lung cancer
- Squamous cell carcinoma
- Thyroid cancer
Hematologic Tumors
- Acute lymphocytic leukemia
- Acute myeloid leukemia
- Chronic lymphocytic leukemia
- Diffuse large B-cell lymphoma
- Lymphoma
- Multiple myeloma
- Myelodysplastic syndrome
Adaptive Trial Design and Management
- First-in-human dose finding
- Basket trials
- Phase I-II designs and cohort selection/expansion
- Combination therapies
- Palliative care
Supportive Care
- Cancer breakthrough pain
- Cancer cachexia
- Chemotherapy-induced anemia
- Chemotherapy-induced nausea and vomiting
- Chemotherapy-induced neutropenia
- Chemotherapy-induced thrombocytopenia
- Oral mucositis
- Tumor lysis syndrome